Marie-Isabel Murray
Overview
Explore the profile of Marie-Isabel Murray including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
60
Followers
0
Related Specialty
Related Specialty
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mas-Peiro S, Seppelt P, de Rosa R, Murray M, Yogarajah J, Berkowitsch A, et al.
Front Cardiovasc Med
. 2020 Dec;
7:605257.
PMID: 33330669
Both EPO levels and anemia have shown prognostic value in several cardiac disorders. An observational study with a prospective follow-up was performed to investigate their independent prognostic roles in severe...
2.
Mas-Peiro S, Hoffmann J, Seppelt P, de Rosa R, Murray M, Walther T, et al.
Acta Cardiol
. 2020 May;
76(6):615-622.
PMID: 32396499
Background: Nutritional status predicts outcomes after TAVR. Predictive value of Prognostic Nutritional Index (PNI) was investigated in patients undergoing TAVR, and compared to other nutritional indexes. Methods: A cohort of...
3.
Murray M, Hofmann E, de Rosa R, Mas-Peiro S, Seppelt P, Walther T, et al.
J Invasive Cardiol
. 2020 Mar;
32(3):82-87.
PMID: 32123140
Objective: The aim of this study was to evaluate hemodynamic outcome, structural valve deterioration, and bioprosthetic valve failure beyond 5 years after transcatheter aortic valve replacement (TAVR). Methods: Demographic, procedural,...
4.
de Rosa R, Murray M, Schranz D, Mas-Peiro S, Esmaeili A, Zeiher A, et al.
Catheter Cardiovasc Interv
. 2019 Oct;
96(3):E341-E347.
PMID: 31631509
Objectives: We investigated whether transcatheter aortic valve replacement (TAVR) results in a short-term decrease in left atrium (LA) size and whether such decrease may predict patients' clinical outcome. Background: Increased...
5.
Murray M, Bonet M, Naci H, Zeiher A
J Atr Fibrillation
. 2019 May;
11(4):2069.
PMID: 31139282
Introduction: The objective of this study was to evaluate the cost-effectiveness of the treatment with cryoballoon (CB) compared to the standard treatment with traditional irrigated radiofrequency (RF) ablation for pulmonary...
6.
Murray M, Arnold A, Younis M, Varghese S, Zeiher A
Clin Res Cardiol
. 2018 Mar;
107(8):658-669.
PMID: 29564527
Objective: The aim of this study was to evaluate the clinical efficacy and safety outcomes of the treatment with cryoballoon (CB) compared to the treatment with traditional irrigated radiofrequency ablation...
7.
Murray M, Geis N, Pleger S, Kallenbach K, Katus H, Bekeredjian R, et al.
J Interv Cardiol
. 2015 Feb;
28(1):109-16.
PMID: 25689554
Background: TAVR has become an established treatment for severe symptomatic aortic stenosis in patients with high surgical risk. The latest generation of the balloon-expandable Edwards Sapien device, the Sapien 3,...
8.
Murray M, Geis N, Pleger S, Katus H, Bekeredjian R, Chorianopoulos E
J Interv Cardiol
. 2014 Jan;
27(2):191-8.
PMID: 24433399
Background: Transcatheter aortic valve implantation has become an established treatment for severe aortic stenosis in patients with high surgical risk. Due to its specific design, the self-expanding 31 mm CoreValve...